We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Roche, Allergan Sue Apotex Again Over Acular Patent

Law360 (June 6, 2005, 12:00 AM EDT) -- Swiss drug maker Roche and licensee Allergan Inc. have sued Canadian generics maker Apotex in a California federal court over its plans to make a generic version of the eye-inflammation treatment Acular.

The complaint, filed by Roche Palo Alto LLC and Allergan, was filed shortly after the U.S. Court of Appeals for the Federal Circuit granted Apotex a second chance to seek the invalidation of a patent for Acular.

Apotex filed an abbreviated new drug application with the U.,S. Food and Drug Administration for Acular with...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.